Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Joseph Hassett"'
Autor:
Pamela G. Kidd, Joseph Hassett, Raul C. Braylan, Lawrence W. Diamond, Margaret Johnson, Susan K. Atwater, Catherine P. Leith, Doyen T. Nguyen
Publikováno v:
Cytometry. 30:245-248
Publikováno v:
American Journal of Hematology. 52:150-154
Compared with subjects with homozygous SS disease (Hb SS), persons with hemoglobin SC (Hb SC) are known to have a more gradual loss of splenic function, a lower incidence of bacterial infections, and fewer end-organ failures. We studied hematological
Autor:
John W. Parker, Darleen R. Powars, Pei Yu Ku, Charles H. Pegelow, James W. Mosley, Joseph Hassett, Eva Operskalski, Wing Yen Wong, Margaret W. Hilgartner, Cage S. Johnson, Sharada A. Sarnaik, Yi Zhou
Publikováno v:
Blood. 85:2091-2097
Transfusions purportedly induce dysfunction of cell-mediated immunity in sickle cell anemia (SCA). We studied hematologic and lymphocytic indices in 173 human immunodeficiency virus (HIV)-negative subjects with SCA and 131 black controls. Children ag
Autor:
Anne Cross, Henry W. Murray, Joseph Hassett, Sandi Sledz, Henry S. Sacks, Lisa M. Dunkle, Walter Weiss, Robert E. Anderson, Kathleen Squires
Publikováno v:
Journal of Infectious Diseases. 171:S123-S130
In a phase I trial of stavudine in AIDS or AIDS-related complex (ARC), antiviral effects and safety were assessed in 41 patients treated with dosages of 0.5-12.0 mg/kg/day. Among evaluable patients, 10% increases in CD4 lymphocyte counts were sustain
Autor:
Yi Zhou, Richard B. Counts, Joseph Hassett, Elizabeth Donegan, Eva Operskalski, George F. Gjerset, John W. Parker, Malcolm C. Pike, James W. Mosley, Mary Ann Fletcher, Carol K. Kasper
Publikováno v:
Blood. 84:1666-1671
Low- and intermediate-purity clotting-factor therapies are believed to accelerate human immunodeficiency virus (HIV) progression in hemophiliacs through adverse immune effects of the other plasma proteins in the preparations. To investigate this post
Autor:
Elizabeth Donegan, Malcolm C. Pike, Joseph Hassett, James W. Mosley, Mary Ann Fletcher, John W. Parker, Louis M. Aledort, George F. Gjerset, Hang Lee, Richard B. Counts
Publikováno v:
Blood. 82:1351-1357
Patients with hemophilia A without human immunodeficiency virus type 1 (HIV-1) infection have lower CD4+ counts and CD4+/CD8+ ratios than controls. This is usually interpreted as a therapy-induced immunodeficiency. Our data re-examine the effect of t
Autor:
Stanley P. Azen, John W. Parker, Joseph H. Kaplan, Joseph Hassett, James W. Mosley, Tamara Odom-Maryon, Eva Operskalski, Donna C. Boone, Diane Scott, Daniel P. Stites, Joyce C. Niland, Bernard Adelsberg, Mary Ann Fletcher, Harry E. Prince, George F. Gjerset
Publikováno v:
Clinical Immunology and Immunopathology. 55:187-220
The Transfusion Safety Study (TSS) is a multicenter, cooperative investigation of factors that may determine the occurrence and modify the expression of transusion-transmitted infections. A flow cytometry laboratory was established in each of the six
Publikováno v:
Clinical Infectious Diseases. 20:S266-S268